Menu Search
Equities

CardieX Ltd

CDX:ASX

CardieX Ltd

Actions
Health CareMedical Equipment and Services
  • Price (AUD)0.135
  • Today's Change-0.015 / -10.00%
  • Shares traded1.36m
  • 1 Year change--
  • Beta1.7411
Data delayed at least 20 minutes, as of Nov 15 2024 05:10 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in AUDIncome statement in AUDView more

Year on year CardieX Ltd grew revenues 129.87% from 4.86m to 11.18m. Additionally the company has reduced the cost of goods sold, selling, general and administrative expenses and debt expenses (all as percentages of sales). These changes narrowed profitability losses from -18.89m to -6.77m.
Gross margin92.86%
Net profit margin-60.53%
Operating margin-39.04%
Return on assets-49.77%
Return on equity-405.22%
Return on investment-313.68%
More ▼

Cash flow in AUDView more

In 2024, cash reserves at CardieX Ltd fell by 234.89k. Cash Flow from Financing totalled 7.59m or 67.93% of revenues. In addition the company used 7.72m for operations while cash used for investing totalled 118.41k.
Cash flow per share--
Price/Cash flow per share--
Book value per share0.0139
Tangible book value per share0.0118
More ▼

Balance sheet in AUDView more

CardieX Ltd has a Debt to Total Capital ratio of 48.59%.
Current ratio1.28
Quick ratio0.9687
Total debt/total equity0.945
Total debt/total capital0.4859
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.